Authors


Teri Pearlstein, MD

Latest:

Postpartum Psychosis: Updates and Clinical Issues

The authors focus on the epidemiology of postpartum psychosis, its clinical presentation, etiology, treatment, and strategies to prevent its recurrence.


Terry Rabinowitz, MD, DDS

Latest:

Telepsychiatry for Vulnerable and Underserved Populations

When timely psychiatric care or consultation is difficult or impossible to obtain, telepsychiatry may be an acceptable, economical, and effective alternative.


Teruo Hayashi, MD, PhD

Latest:

Understanding the Role of Sigma-1 Receptors in Psychotic Depression

Selective serotonin reuptake inhibitors have been shown effective in the treatment of depression with psychosis. This efficacy appears to correlate with the SSRIs’ level of affinity at the sigma-1 receptors in the brain. What role does the sigma-1 receptor play in psychotic depression? Based on this role, are there implications for other treatments?


THE AMERICAN ASSOCIATION OF COMMUNITY PSYCHIATRISTS

Latest:

A Crisis in the Public Service Psychiatric Workforce

Here's what's known about the growing shortage of psychiatrists -- why it's happening-- and possible solutions.


Theodore A. Henderson, MD, PhD

Latest:

The Anti-Youth Pill? Alprazolam Toxicity Can Add Years to Brain Age and Appearance

Here's a case that illustrates the potential for alprazolam to create a dementia-like appearance-not to mention a premature aging of the patient.


Theodore B. Feldmann, MD

Latest:

The Role of Mental Health Consultants on Hostage Negotiation Teams

Hostage and barricade situations occur frequently in law enforcement practice. Commonly, police deal with hostage/barricade subjects whose motivation is influenced by psychiatric illness, substance abuse or extreme emotional states. It has been argued that mentally ill people comprise 50% of all hostage/barricade subjects. How can psychiatrists assist in defusing these intense situations?


Theodore E. Weltzin, MD

Latest:

Eating Disorders in Males

The article focuses on eating disorders in males and presents information on similarities and differences between males and females as they relate to risk factors, clinical presentation, and treatment.


Theodore H. Whitfield, ScD

Latest:

Agitation in Older Adults

Agitation in older adults is frequently associated with multiple psychiatric and medical conditions and comorbidities. It commonly occurs in patients with anxiety, affective illness, psychosis, dementia, stroke, brain injury, delirium, or pain.


Theodore Sunder, MD

Latest:

Nonverbal Learning Disabilities and Sensory Processing Disorders

In our presentation at the 2006 annual meeting of the American Academy of Child and Adolescent Psychiatry, we suggested that child psychiatrists who come across a child with the profile of the following hypothetical case should consider whether the child may have deficits that are not currently covered by DSM-IV nosology: either a nonverbal learning disability (NVLD) or a sensory processing disorder (SPD).


Theresa A. Yuschok, MD

Latest:

Spiritual Matters: Inspiring Clinical Care

A patient’s spiritual “framework” can hold the key to therapeutic breakthroughs.


Theresa Garton, MD

Latest:

Clinical Reflections: Making Difficult Choices

Psychiatrists can play a vital role in determining whether or not a patient will be a good candidate for an organ transplant. Using a case vignette, Dr. Garton explains how she helps a transplant team make the best possible decision.


Theresa S. Garton, MD

Latest:

In Support of Early Psychotherapy Training

Recent reports have noted an alarming decrease in the practice of psychotherapy among psychiatrists.


Thomas A. Grieger, MD

Latest:

Psychiatric and Societal Impacts of Terrorism

The impact of terrorism reaches many aspects of health and health care: acute and chronic symptoms of anxiety and depression, changes in health-related behaviors, and long-term strain and tension.


Thomas A. Hennebry, MD

Latest:

Anxiety Disorders: Aortic Aneurysm in the Differential?

Worsening anxiety is a common symptom that may result in psychiatric consultation or evaluation in an emergency setting. Aneurysms are rarely considered in the medical differential for anxiety disorders, and the available literature and research regarding this possible connection are very limited. Overlooking this diagnosis, however, can have disastrous consequences. Here we present 2 case reports as well as a review of the literature regarding a possible relationship between aortic and thoracic aneurysms and psychiatric symptoms.


Thomas C. Neylan, MD

Latest:

Sleep Disturbances Associated With Posttraumatic Stress Disorder

The National Comorbidity Survey estimates that approximately 50% of the population in the United States is exposed to traumatic events and that the lifetime prevalence of posttraumatic stress disorder (PTSD) is approximately 7.8%.



Thomas E. Brown, PhD

Latest:

Mini Quiz: ADHD in Young Adults

What do you really know about ADHD in young adults? Take this quiz and find out.


Thomas E. Finucane, MD

Latest:

Commercial Influence on Psychiatric Drug Studies

A discussion of the evidence that the pharmaceutical industry influences how physicians evaluate drugs in ways that encourage sales of their products and that are not always in the best interests of the patient.


Thomas E. Hansen, MD

Latest:

Psychologist Prescribing Privileges in Oregon: A Potentially Dangerous Non-solution

As a fellow Oregonian, I concur with Dr Jim Phelps that the topic of psychologist prescribing is highly complex, and that even balanced opinions generate “affective discharge” approaching “invective."


Thomas E. Schlaepfer, MD

Latest:

Neurostimulation Treatments in Psychiatry: An Overview and Recent Advances

There have been considerable advances in the research on and clinical use of neurostimulation for psychiatric disorders, especially mood disorders and MDD. Three of the most recognized are reviewed here. An experimental new treatment-- trigeminal nerve stimulation-- is also briefly discussed.


Thomas F. Anders, MD

Latest:

Child and Adolescent Psychiatry: The Next 10 Years

Psychiatry is changing so rapidly that it seems impossible to predict 1 year ahead, let alone 10 years. In 1967, when my psychiatry training ended, the community psychiatry movement had just begun, DSM-II was in the works, and the biological revolution was still around the corner.


Thomas G. Gutheil, MD

Latest:

What Are Best Practices for Psychiatrists When Serving As Expert Witnesses?

An expert shares 7 tips for effectively serving as an expert witness in court.


Thomas H. Mcglashan, MD

Latest:

Drs McGlashan and Woods Respond to Dr Feinberg

Dr Feinberg takes exception to much of what we wrote, or what he thinks we wrote, in our article “Early Antecedents and Detection in Schizophrenia”. We will do our best to reply to his criticisms of what we did write and try to point out where he is shadowboxing at issues that he has created but that we do not hold or endorse.


Thomas J. Raedler, MD

Latest:

The Muscarinic Hypothesis of Schizophrenia

Since the discovery of dopamine as a neurotransmitter in the late 1950s, schizophrenia has been associated with changes in the dopaminergic system. However, the dopamine hypothesis of schizophrenia cannot explain all the symptoms associated with this disorder. Therefore, research has also focused on the role of other neurotransmitter systems, including glutamate, g-aminobutyric acid, serotonin, and acetylcholine (ACh) in schizophrenia.


Thomas Joiner, PhD

Latest:

Understanding and Overcoming the Myths of Suicide

What goes on in the minds of those who attempt suicide? Here: a psychologist who explores the myths that surround suicide notes "We need to get it in our heads that suicide is not easy, painless, cowardly, selfish, vengeful, self-masterful, nor rash."


Thomas L. Schwartz, MD

Latest:

Introduction: Looking to the Future of Psychopharmacology

The focus of this Special Report is on some future-oriented aspects of psychopharmacology. First, it is an eclectic set of articles that cover treating resistant depression, using currently illegal drugs to treat psychiatric problems, and finally the potential of using vaccines to treat substance use disorders.


Thomas Lehner, PhD, MPH

Latest:

The OPTICS Project: An Open-Science Framework for the Analysis of Clinical Trial Data

A report of initiatives that have raised awareness of and promoted data sharing and data transparency in order to advance science and improve public health and health care.


Thomas M. Kelly, PhD

Latest:

The Therapeutic Alliance and Psychosocial Interventions for Successful Treatment of Addiction

A discussion of treatment options to help foster the most effective psychosocial treatment for addiction.


Thomas Meeks, MD

Latest:

Drugs, Death, and Disconcerting Dilemmas

An Overview of Antipsychotic Use in Older Adults


Thomas P. Kalman, MS, MD

Latest:

Accept Insurance? I Wish I Could

There are not enough participating psychiatrists to accommodate all who would seek treatment if it were affordable. This is not a good situation.

© 2025 MJH Life Sciences

All rights reserved.